Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

NCT02568566 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

201

Enrollment

NIH

Sponsor class

Conditions

Human Papillomavirus-Related Carcinoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Recombinant Human Papillomavirus Nonavalent Vaccine

Sponsor

National Cancer Institute (NCI)